Pediatric Critical Care Resource Use by Children with Medical Complexity

Titus Chan1, Jonathan Rodean2, Troy Richardson2

  • 1Department of Pediatrics, University of Washington/Seattle Children's Hospital, Seattle, WA.

Insights

Children with complex chronic diseases (C-CD) disproportionately use the majority of pediatric intensive care unit (ICU) resources. Focusing on this high-need population is key for improving quality and cost-effectiveness in pediatric critical care.

Area of Science:

  • Pediatric critical care medicine
  • Health services research
  • Medical complexity

Background:

  • Understanding resource utilization in pediatric intensive care units (ICUs) is crucial for optimizing healthcare delivery.
  • Children admitted to ICUs exhibit varying degrees of medical complexity, influencing their healthcare needs and resource consumption.

Purpose of the Study:

  • To investigate the proportionate use of critical care resources among children with different levels of medical complexity.
  • To analyze resource allocation in pediatric ICUs within tertiary-care children's hospitals based on patient complexity.

Main Methods:

  • Retrospective, cross-sectional study of pediatric ICU admissions from January 2012 to December 2013.
  • Utilized the Pediatric Medical Complexity Algorithm to categorize patients into: no chronic disease, noncomplex chronic disease (NC-CD), and complex chronic disease (C-CD).
  • Analyzed and stratified baseline demographics, hospital costs, and critical care resource use by complexity group.

Main Results:

  • Over 136,000 pediatric ICU admissions were analyzed; 53% were classified as C-CD.
  • Patients with C-CD demonstrated the highest ICU resource use individually and accounted for over 75% of total ICU resources at the hospital level.
  • Complex chronic disease patients consumed the majority of resources including ventilation days, ICU costs, and specialized procedures, while no chronic disease and NC-CD patients used less than 25%.

Conclusions:

  • Children with medical complexity are disproportionate users of critical care resources in children's hospitals.
  • Targeted quality improvement and cost-effectiveness initiatives should prioritize this high-resource utilization population.
  • Further research into resource management for medically complex pediatric patients is warranted.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
692
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
423
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
645
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
1.0K